NCT03043391 2024-04-08Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in ChildrenIstari Oncology, Inc.Phase 1 Completed8 enrolled 9 charts
NCT02684058 2023-12-13Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsNovartisPhase 2 Completed151 enrolled 45 charts 1 FDA
NCT02764151 2020-01-27First in Patient Study for PF-06840003 in Malignant GliomasPfizerPhase 1 Terminated17 enrolled 35 charts
NCT00392171 2017-06-07The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)Merck Sharp & Dohme LLCPhase 2 Completed120 enrolled 6 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts